To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CD9TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
479 representative clones for gene CD9 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CX755611 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1 to 741 1 to 740   tiling clone, Submitted on the opposite strand 740/740
(100 %)
4 diff
(99.5 %id)
EB387841 eye, optic nerve .a 81 to 785 1 to 705       705/705
(100 %)
5 diff
(99.3 %id)
BI599179 brain, hypothalamus .a 191 to 1049 7 to 870       864/1119
(77 %)
28 diff
(97.5 %id)
TI_45214962   .a 191 to 1049 133 to 996       864/1245
(69 %)
28 diff
(97.8 %id)
BU189110 melanotic melanoma, cell line, skin .a 197 to 1079 18 to 913       896/981
(91 %)
32 diff
(96.8 %id)
BI767639 pooled lung and spleen .a 200 to 1049 1 to 856       856/856
(100 %)
10 diff
(98.9 %id)
TI_57183869   .a 200 to 1049 31 to 886       856/886
(96 %)
14 diff
(98.5 %id)
BM721364 eye, fetal eye .a 200 to 875 1 to 676   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 676/676
(100 %)
0 diff
(100 %id)
BG697952 skin .a 201 to 1046 1 to 848       848/852
(99 %)
15 diff
(98.3 %id)
BM923252 pooled colon, kidney, stomach .a 201 to 1216 13 to 1037       1025/1038
(98 %)
35 diff
(96.7 %id)
CR619299 adult brain .a 202 to 1401 1 to 1200       1200/1200
(100 %)
0 diff
(100 %id)
BX463539 adult brain, brain .a 202 to 794 1 to 590   fully sequenced,   590/590
(100 %)
5 diff
(99.2 %id)
BI762598 pooled colon, kidney, stomach .a 202 to 1043 1 to 845       845/849
(99 %)
12 diff
(98.6 %id)
BI752800 brain .a 202 to 1049 1 to 853       853/854
(99 %)
7 diff
(99.2 %id)
CA454908   .a 202 to 1080 1 to 893       892/893
(99 %)
18 diff
(98.0 %id)
TI_57214875   .a 202 to 1049 26 to 878       853/879
(97 %)
13 diff
(98.6 %id)
TI_57150496   .a 202 to 1043 30 to 874       845/878
(96 %)
16 diff
(98.2 %id)
BM015879 breast, mammary adenocarcinoma, cell line .a 203 to 1033 1 to 839       839/843
(99 %)
9 diff
(99.0 %id)
TI_59394246   .a 203 to 1033 133 to 971       839/843
(99 %)
9 diff
(99.0 %id)
AY966455 bladder .a 206 to 1436 1 to 1232   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1232/1232
(100 %)
1 diff
(100.0 %id)
NM_001769.2   .a 206 to 1436 1 to 1231   RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1231/1231
(100 %)
0 diff
(100 %id)
X60111 malignant ascitic effusion .a 206 to 1325 1 to 1120       1120/1120
(100 %)
1 diff
(100.0 %id)
CX781931 human embryonic stem cells .a 207 to 1049 1 to 843   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 843/843
(100 %)
0 diff
(100 %id)
CX866654 embryonic stem .a 208 to 968 1 to 761   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 761/761
(100 %)
0 diff
(100 %id)
BU166053 melanotic melanoma, skin .a 209 to 1026 1 to 832       832/842
(98 %)
18 diff
(97.9 %id)
CR599322 Neuroblastoma Cot 50-normalized .a 211 to 1404 1 to 1194       1194/1194
(100 %)
0 diff
(100 %id)
AL530117 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 211 to 884 1 to 673   fully sequenced,   673/673
(100 %)
8 diff
(98.9 %id)
BG821407 adenocarcinoma cell line, colon .a 230 to 1054 7 to 828       822/828
(99 %)
14 diff
(98.4 %id)
CA772232 Pancreas, Purified pancreatic islet .a 233 to 695 1 to 463   fully sequenced,   463/463
(100 %)
1 diff
(99.8 %id)
BQ214422 embryonal carcinoma, cell line, testis .a 234 to 1038 1 to 814       814/902
(90 %)
18 diff
(98.1 %id)
BF342449 brain, glioblastoma with EGFR amplification .a 238 to 1054 1 to 820       820/1115
(73 %)
31 diff
(97.3 %id)
BG741271 skin .a 239 to 1054 1 to 815       815/960
(84 %)
7 diff
(99.3 %id)
BI755813 brain .a 239 to 1019 1 to 779       779/779
(100 %)
2 diff
(99.8 %id)
TI_57217032   .a 239 to 1019 36 to 814       779/814
(95 %)
8 diff
(99.1 %id)
BU786442 Pancreas, Purified pancreatic islet .a 279 to 883 1 to 605       605/605
(100 %)
0 diff
(100 %id)
AI345975 adenocarcinoma, colon .a 580 to 1434 853 to 2       852/863
(98 %)
17 diff
(98.1 %id)
AI354345 esophagus, squamous cell carcinoma .a 599 to 1436 837 to 7       831/846
(98 %)
41 diff
(95.2 %id)
TI_149296248   .a 600 to 1436 920 to 88   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 833/965
(86 %)
10 diff
(99.0 %id)
CD677295 eye, Trabecular meshwork .a 608 to 1207 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
CN262783 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 629 to 1144 1 to 516       516/516
(100 %)
0 diff
(100 %id)
CN262786 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 629 to 1239 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
TI_149311381   .a 635 to 1434 885 to 92   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 794/987
(80 %)
8 diff
(99.2 %id)
TI_154104076   .a 635 to 1436 877 to 83   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 795/936
(84 %)
7 diff
(99.3 %id)
AJ707908 heart .a 638 to 1174 15 to 549       535/549
(97 %)
6 diff
(99.0 %id)
BY799651 eye .a 642 to 1147 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
BX473502   .a 648 to 1074 1 to 427       427/427
(100 %)
0 diff
(100 %id)
AW860639 colon .a 650 to 991 1 to 342       342/342
(100 %)
0 diff
(100 %id)
CA771952 Pancreas, Purified pancreatic islet .a 654 to 1441 792 to 5   fully sequenced,   788/792
(99 %)
1 diff
(99.9 %id)
BF874019 lung_tumor .a 663 to 1013 1 to 351       351/351
(100 %)
0 diff
(100 %id)
CR598565 HeLa cells Cot 25-normalized .a 663 to 1441 1 to 779   tiling clone,   779/779
(100 %)
0 diff
(100 %id)
BX384079   .a 663 to 1441 1 to 779   fully sequenced,   779/779
(100 %)
2 diff
(99.8 %id)
W20026 parathyroid gland, parathyroid tumor .a 686 to 950 1 to 263       263/276
(95 %)
11 diff
(96.1 %id)
BX463538 adult brain, brain .a 733 to 1401 671 to 1   fully sequenced,   671/671
(100 %)
7 diff
(99.0 %id)
AL530116 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 823 to 1404 581 to 1   fully sequenced,   581/581
(100 %)
4 diff
(99.4 %id)
BX384078   .a 823 to 1430 608 to 1   fully sequenced,   608/608
(100 %)
3 diff
(99.6 %id)
BU740438 eye, fetal eye .a 823 to 1436 632 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
CX866595 embryonic stem .a 907 to 1434 555 to 27   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 529/529
(100 %)
2 diff
(99.7 %id)
DB576636 hypothalamus .a 944 to 1436 1 to 493     Submitted on the opposite strand 493/493
(100 %)
1 diff
(99.8 %id)
AW269482 lung, two pooled squamous cell carcinomas .a 945 to 1441 498 to 1       498/498
(100 %)
1 diff
(99.8 %id)
DB544328 hippocampus .a 947 to 1436 1 to 491     Submitted on the opposite strand 491/492
(99 %)
2 diff
(99.6 %id)
EC450528 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC450542 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC450655 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC465150 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC465188 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC465437 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC480182 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC494371 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC523719 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC525422 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC537969 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC552523 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC552574 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC552729 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC554467 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC567231 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC567235 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
EC568357 Prostate .a 948 to 1032 85 to 1       85/85
(100 %)
0 diff
(100 %id)
DB550207 hippocampus .a 948 to 1434 1 to 487     Submitted on the opposite strand 487/489
(99 %)
3 diff
(99.4 %id)
BM783139 stomach .a 959 to 1434 1 to 476       476/476
(100 %)
0 diff
(100 %id)
FN149990 breast carcinoma .a 960 to 1051 92 to 1     Submitted on the opposite strand 92/92
(100 %)
0 diff
(100 %id)
CB242564 Human Lung Epithelial cells, lung .a 960 to 1436 495 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 477/477
(100 %)
0 diff
(100 %id)
BY999476   .a 961 to 1434 1 to 474     Submitted on the opposite strand 474/478
(99 %)
1 diff
(99.8 %id)
BY999495   .a 961 to 1431 1 to 471     Submitted on the opposite strand 471/474
(99 %)
5 diff
(99.0 %id)
BY999798   .a 961 to 1434 1 to 474     Submitted on the opposite strand 474/476
(99 %)
1 diff
(99.8 %id)
AA215892   .a 962 to 1215 1 to 254       254/254
(100 %)
0 diff
(100 %id)
AA299593 uterus .a 967 to 1254 1 to 287       287/288
(99 %)
2 diff
(99.4 %id)
AI922602 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 968 to 1441 477 to 4       474/477
(99 %)
0 diff
(100 %id)
DB548655 hippocampus .a 970 to 1430 1 to 462     Submitted on the opposite strand 462/462
(100 %)
1 diff
(99.8 %id)
AI275792 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 973 to 1436 464 to 1       464/464
(100 %)
0 diff
(100 %id)
BU784717 Pancreas, Purified pancreatic islet .a 996 to 1441 446 to 1       446/446
(100 %)
0 diff
(100 %id)
CX781878 human embryonic stem cells .a 1019 to 1441 447 to 25   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 423/423
(100 %)
3 diff
(99.3 %id)
N90536 parathyroid gland, parathyroid tumor .a 1197 to 1441 245 to 1       245/247
(99 %)
1 diff
(99.6 %id)
AK296332 thalamus .b 1 to 983 1 to 983 exact tiling clone,   983/983
(100 %)
0 diff
(100 %id)
DA159137 amygdala .b 964 to 1530 2 to 569   tiling clone, capped   568/568
(100 %)
4 diff
(99.3 %id)
CR599016 Neuroblastoma Cot 25-normalized .c 1 to 1553 1 to 1553 exact tiling clone,   1553/1553
(100 %)
0 diff
(100 %id)
AL523128 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1 to 823 1 to 821   fully sequenced,   821/821
(100 %)
2 diff
(99.8 %id)
BX473506   .c 358 to 788 1 to 432       432/432
(100 %)
4 diff
(99.1 %id)
BU930810 Prostate .c 358 to 1065 1 to 711       711/777
(91 %)
5 diff
(99.4 %id)
BP274051   .c 360 to 909 1 to 550       550/550
(100 %)
5 diff
(99.1 %id)
AL047161 uterus .c 362 to 779 1 to 419       419/419
(100 %)
3 diff
(99.3 %id)
BM743340 Ascites, stomach .c 362 to 891 1 to 532       532/532
(100 %)
3 diff
(99.5 %id)
BM785387 Ascites, stomach .c 362 to 1089 1 to 727       727/727
(100 %)
1 diff
(99.9 %id)
BM766814 Ascites, stomach .c 362 to 923 1 to 562       562/562
(100 %)
0 diff
(100 %id)
BM771063 Ascites, stomach .c 362 to 912 1 to 551       551/551
(100 %)
0 diff
(100 %id)
BM748513 Ascites, stomach .c 362 to 809 1 to 448       448/448
(100 %)
2 diff
(99.6 %id)
BM748313 Ascites, stomach .c 362 to 900 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
BM758254 Ascites, stomach .c 362 to 923 1 to 562       562/562
(100 %)
0 diff
(100 %id)
BM758764 Ascites, stomach .c 362 to 1027 1 to 666       666/666
(100 %)
0 diff
(100 %id)
BM757555 Ascites, stomach .c 362 to 901 1 to 540       540/540
(100 %)
0 diff
(100 %id)
BM757587 Ascites, stomach .c 362 to 790 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
BM758499 Ascites, stomach .c 362 to 999 1 to 638       638/638
(100 %)
1 diff
(99.9 %id)
BM758560 Ascites, stomach .c 362 to 1037 1 to 676       676/676
(100 %)
0 diff
(100 %id)
BM772532 Ascites, stomach .c 362 to 997 1 to 636       636/636
(100 %)
0 diff
(100 %id)
BM750621 Ascites, stomach .c 363 to 904 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
CD515937 White Matter .c 365 to 975 1 to 613       613/977
(62 %)
8 diff
(99.2 %id)
BG696893 skin .c 366 to 956 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
BU579984.
matches multiple genes
insulinoma, Pancreas .c 366 to 789 1 to 424     also hits gene snoysnee 424/424
(100 %)
3 diff
(99.3 %id)
CV569098 cornea, eye .c 366 to 974 1 to 609       609/609
(100 %)
0 diff
(100 %id)
CV569293 cornea, eye .c 366 to 935 1 to 570       570/570
(100 %)
0 diff
(100 %id)
CV571287 cornea, eye .c 369 to 981 1 to 613       613/614
(99 %)
1 diff
(99.9 %id)
BF038821 adenocarcinoma, ovary .c 374 to 947 1 to 573       573/576
(99 %)
2 diff
(99.7 %id)
DA450614 tongue, tumor tissue .c 381 to 958 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BM353298 Pancreas, Purified pancreatic islet .c 384 to 990 1 to 607       607/607
(100 %)
2 diff
(99.7 %id)
BP214789 corpus callosum .c 387 to 968 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP214819 corpus callosum .c 387 to 967 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BM763293 myeloma .c 401 to 911 1 to 510       510/510
(100 %)
2 diff
(99.7 %id)
BM508905 insulinoma, Pancreas .c 403 to 987 8 to 592       585/592
(98 %)
6 diff
(99.0 %id)
CK905325 insulinoma, Pancreas .c 403 to 958 8 to 563       556/563
(98 %)
6 diff
(99.0 %id)
CV023613 mixed .c 445 to 1099 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BM832449 stomach .c 445 to 767 1 to 324       324/324
(100 %)
1 diff
(99.7 %id)
BP263407 small intestine .c 470 to 1052 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP332980 salivary gland .c 489 to 1065 1 to 578       578/582
(99 %)
2 diff
(99.7 %id)
BM761548 myeloma .c 521 to 1037 1 to 517       517/517
(100 %)
0 diff
(100 %id)
FN045986 breast carcinoma .c 526 to 614 89 to 1     Submitted on the opposite strand 89/89
(100 %)
0 diff
(100 %id)
BM854402 stomach .c 534 to 996 1 to 463       463/463
(100 %)
0 diff
(100 %id)
BF798849 colon_ins .c 548 to 801 1 to 254       254/254
(100 %)
1 diff
(99.7 %id)
FN060711 breast carcinoma .c 564 to 654 91 to 1     Submitted on the opposite strand 91/91
(100 %)
0 diff
(100 %id)
FN106662 breast carcinoma .c 581 to 675 1 to 95       95/95
(100 %)
0 diff
(100 %id)
DA992278 synovial membrane tissue from rheumatioidarthritis .c 597 to 848 2 to 254   capped   253/253
(100 %)
1 diff
(99.7 %id)
BM842960 lymph node, stomach .c 601 to 1215 1 to 614       614/614
(100 %)
6 diff
(99.1 %id)
BM709514 eye, optic nerve .c 605 to 1177 1 to 573       573/578
(99 %)
2 diff
(99.7 %id)
BM716259 eye, optic nerve .c 605 to 1129 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
CN262780 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 607 to 1158 1 to 552       552/552
(100 %)
0 diff
(100 %id)
CB119487 Liver .c 611 to 931 1 to 321       321/321
(100 %)
0 diff
(100 %id)
CB119587 Liver .c 611 to 950 1 to 340       340/340
(100 %)
2 diff
(99.5 %id)
FN074555 breast carcinoma .c 612 to 703 92 to 1     Submitted on the opposite strand 92/92
(100 %)
0 diff
(100 %id)
BP295796   .c 626 to 1207 1 to 584       584/584
(100 %)
5 diff
(99.2 %id)
EC452170 Prostate .c 633 to 725 1 to 93       93/93
(100 %)
0 diff
(100 %id)
AA341151 Kidney .c 635 to 973 1 to 340       340/340
(100 %)
3 diff
(99.2 %id)
BM741265 stomach .c 635 to 737 1 to 103       103/103
(100 %)
1 diff
(99.1 %id)
AA337736 endometrium .c 637 to 926 1 to 290       290/290
(100 %)
2 diff
(99.4 %id)
AA378134 synovial membrane .c 642 to 996 1 to 354       354/354
(100 %)
1 diff
(99.8 %id)
BG432680 Kidney .c 646 to 1374 1 to 720       700/854
(81 %)
21 diff
(97.6 %id)
FN136111 breast carcinoma .c 660 to 755 96 to 1     Submitted on the opposite strand 96/96
(100 %)
0 diff
(100 %id)
AA385436 thyroid gland .c 744 to 1008 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
AL562172 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 762 to 1548 791 to 6   fully sequenced,   786/791
(99 %)
10 diff
(98.8 %id)
BF868964 lung_tumor .c 791 to 1141 351 to 1     Submitted on the opposite strand 351/351
(100 %)
0 diff
(100 %id)
BQ084256 stomach .c 799 to 1107 1 to 307       307/307
(100 %)
2 diff
(99.4 %id)
EC462082 Prostate .c 800 to 910 1 to 110       110/110
(100 %)
1 diff
(99.1 %id)
DV462656 cochlea, ear .c 834 to 959 126 to 1     Submitted on the opposite strand 126/126
(100 %)
1 diff
(99.3 %id)
FN049865 breast carcinoma .c 991 to 1077 87 to 1     Submitted on the opposite strand 87/87
(100 %)
0 diff
(100 %id)
EC564158 Prostate .c 1018 to 1098 1 to 81       81/81
(100 %)
0 diff
(100 %id)
FN079275 breast carcinoma .c 1030 to 1110 1 to 81       81/81
(100 %)
0 diff
(100 %id)
DB545114 hippocampus .c 1106 to 1560 1 to 455     Submitted on the opposite strand 455/457
(99 %)
1 diff
(99.8 %id)
AA948377 2 pooled tumors (clear cell type), Kidney .c 1107 to 1562 459 to 4       456/459
(99 %)
0 diff
(100 %id)
CD679491 eye, Trabecular meshwork .c 1109 to 1562 1 to 454   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 454/454
(100 %)
4 diff
(99.2 %id)
AI288260 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1110 to 1562 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AJ710247 heart .c 1111 to 1555 445 to 1     Submitted on the opposite strand 445/445
(100 %)
0 diff
(100 %id)
BM986830 mixed .c 1113 to 1562 464 to 15   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 450/450
(100 %)
1 diff
(99.8 %id)
AI889786 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1117 to 1561 447 to 3       445/447
(99 %)
0 diff
(100 %id)
AI890535 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1117 to 1563 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
AW470035 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1117 to 1562 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AW770456 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 1117 to 1564 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AA987320 carcinoid, lung .c 1119 to 1567 448 to 1       448/448
(100 %)
2 diff
(99.6 %id)
AI804207 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1119 to 1558 439 to 1       439/439
(100 %)
1 diff
(99.8 %id)
AI683757 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1121 to 1568 468 to 21   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 448/448
(100 %)
2 diff
(99.6 %id)
AI654469 ovary, tumor, 5 pooled (see description) .c 1122 to 1562 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AI653978 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1123 to 1564 453 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 442/442
(100 %)
0 diff
(100 %id)
DB539020 hippocampus .c 1124 to 1565 1 to 443     Submitted on the opposite strand 443/443
(100 %)
2 diff
(99.6 %id)
AW243847 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1125 to 1562 438 to 1       438/438
(100 %)
0 diff
(100 %id)
AI003581 parathyroid gland, parathyroid tumor .c 1127 to 1574 455 to 8   tiling clone,   448/455
(98 %)
0 diff
(100 %id)
AI831369 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1127 to 1561 435 to 1       435/435
(100 %)
1 diff
(99.8 %id)
AI689372 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1128 to 1564 440 to 3       438/440
(99 %)
0 diff
(100 %id)
AW088401 ovary, tumor, 5 pooled (see description) .c 1129 to 1558 432 to 1       432/432
(100 %)
3 diff
(99.4 %id)
AI281294 adenocarcinoma, colon .c 1131 to 1562 433 to 2       432/433
(99 %)
0 diff
(100 %id)
AI281145 adenocarcinoma, colon .c 1132 to 1562 432 to 2       431/432
(99 %)
0 diff
(100 %id)
AA554687 breast .c 1141 to 1565 426 to 2       425/426
(99 %)
0 diff
(100 %id)
AI871203 anaplastic oligodendroglioma, brain .c 1141 to 1564 435 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 424/424
(100 %)
0 diff
(100 %id)
BF908577 uterus_tumor .c 1144 to 1332 189 to 1     Submitted on the opposite strand 189/189
(100 %)
0 diff
(100 %id)
AI336527 adenocarcinoma, colon .c 1146 to 1562 418 to 2       417/418
(99 %)
0 diff
(100 %id)
BI491788 cochlea, ear .c 1146 to 1567 1 to 423   AAA Submitted on the opposite strand 423/423
(100 %)
2 diff
(99.6 %id)
AI798382 ovary, tumor, 5 pooled (see description) .c 1150 to 1558 409 to 1       409/409
(100 %)
0 diff
(100 %id)
AW104699 ovary, tumor, 5 pooled (see description) .c 1152 to 1564 415 to 3       413/415
(99 %)
0 diff
(100 %id)
AW083700 esophagus, squamous cell carcinoma .c 1158 to 1562 407 to 3       405/407
(99 %)
0 diff
(100 %id)
AI183695 lung .c 1161 to 1563 403 to 1       403/403
(100 %)
1 diff
(99.8 %id)
AI022580 parathyroid gland, parathyroid tumor .c 1162 to 1564 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AW515348 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1170 to 1562 395 to 3       393/395
(99 %)
0 diff
(100 %id)
AI625287 adenocarcinoma, Pancreas .c 1172 to 1564 405 to 13   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 393/393
(100 %)
0 diff
(100 %id)
AI354660 Kidney, renal cell tumor .c 1175 to 1562 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AA508597 colon .c 1192 to 1558 390 to 24   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 367/367
(100 %)
0 diff
(100 %id)
AA492267 Prostate .c 1194 to 1562 382 to 14   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 369/369
(100 %)
0 diff
(100 %id)
AW150128 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1199 to 1558 360 to 1       360/360
(100 %)
0 diff
(100 %id)
EC564446 Prostate .c 1208 to 1320 1 to 112   AAA   112/112
(100 %)
1 diff
(99.2 %id)
AA640721   .c 1210 to 1564 379 to 25   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 355/355
(100 %)
3 diff
(99.2 %id)
AW166455 cervix .c 1214 to 1562 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AA602023   .c 1219 to 1560 1 to 342       342/342
(100 %)
0 diff
(100 %id)
BM991560 lung, Metastatic Chondrosarcoma .c 1219 to 1556 357 to 20   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 338/340
(99 %)
0 diff
(100 %id)
BX497048 Liver .c 1224 to 1507 1 to 284       284/284
(100 %)
1 diff
(99.7 %id)
AA554425 breast .c 1225 to 1558 355 to 22   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 334/334
(100 %)
0 diff
(100 %id)
FN062354 breast carcinoma .c 1227 to 1333 1 to 107       107/108
(99 %)
1 diff
(99.1 %id)
BP336976 coronary artery .c 1228 to 1564 1 to 337   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 337/337
(100 %)
1 diff
(99.8 %id)
FN063017 breast carcinoma .c 1234 to 1341 108 to 1     Submitted on the opposite strand 108/108
(100 %)
0 diff
(100 %id)
AI050907 parathyroid gland, parathyroid tumor .c 1235 to 1562 328 to 1       328/328
(100 %)
0 diff
(100 %id)
AW079690 esophagus, squamous cell carcinoma .c 1239 to 1564 345 to 21   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 325/325
(100 %)
2 diff
(99.4 %id)
AI281853 colon, moderately-differentiated adenocarcinoma .c 1268 to 1564 297 to 1       297/298
(99 %)
0 diff
(100 %id)
BM741811 stomach .c 1280 to 1558 1 to 279   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 279/279
(100 %)
0 diff
(100 %id)
AI684322 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1315 to 1568 254 to 1       254/254
(100 %)
0 diff
(100 %id)
AA828869 ovary .c 1322 to 1568 1 to 247   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 247/247
(100 %)
6 diff
(97.6 %id)
EC551193 Prostate .c 1344 to 1455 1 to 111       111/111
(100 %)
1 diff
(99.1 %id)
D56517   .c 1354 to 1562 1 to 209       209/209
(100 %)
0 diff
(100 %id)
T27681 uterus .c 1368 to 1562 234 to 40   AAA Submitted on the opposite strand 195/201
(97 %)
0 diff
(100 %id)
H88875 cochlea, ear .c 1382 to 1552 1 to 171   fully sequenced,   171/171
(100 %)
0 diff
(100 %id)
CD722718 eye, lacrimal gland .c 1387 to 1558 1 to 172   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 172/172
(100 %)
0 diff
(100 %id)
AA301829 aorta .c 1416 to 1562 181 to 35   AAA Submitted on the opposite strand 147/147
(100 %)
0 diff
(100 %id)
FN057107 breast carcinoma .c 1417 to 1522 1 to 106       106/106
(100 %)
0 diff
(100 %id)
EC554225 Prostate .c 1435 to 1544 1 to 110       110/110
(100 %)
0 diff
(100 %id)
EC473238 Prostate .c 1442 to 1548 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
H88876 cochlea, ear .c 1450 to 1549 100 to 1   fully sequenced,   100/100
(100 %)
0 diff
(100 %id)
AI811103 ovary, tumor, 5 pooled (see description) .c 1481 to 1553 1 to 73     Submitted on the opposite strand 73/73
(100 %)
0 diff
(100 %id)
BU145670 dorsal root ganglia .d 1 to 886 1 to 898 E86G G263R I264H A265C V266R ... tiling clone,   896/905
(99 %)
18 diff
(98.1 %id)
CD516063 White Matter .d 4 to 782 23 to 805   tiling clone,   783/932
(84 %)
13 diff
(98.7 %id)
CD676711 eye, Trabecular meshwork .d 454 to 1025 1 to 572   tiling clone,   572/572
(100 %)
5 diff
(99.2 %id)
BX387785 Placenta Cot 25-normalized .e 1 to 733 1 to 734   tiling clone,   734/834
(88 %)
38 diff
(95.5 %id)
BP316132 pericardium .e 214 to 794 1 to 582   tiling clone,   582/582
(100 %)
3 diff
(99.5 %id)
AW748749 breast .e 510 to 1082 1 to 586       586/591
(99 %)
16 diff
(97.3 %id)
BM709541 eye, optic nerve .e 553 to 875 1 to 323       323/323
(100 %)
0 diff
(100 %id)
BM716306 eye, optic nerve .e 553 to 1008 1 to 456   tiling clone,   456/456
(100 %)
3 diff
(99.4 %id)
U25943   .e 646 to 1007 1 to 361       361/361
(100 %)
2 diff
(99.5 %id)
AW752291 colon .e 671 to 1030 4 to 362       359/362
(99 %)
6 diff
(98.4 %id)
BQ372257 prostate_normal .e 834 to 1038 1 to 208       208/213
(97 %)
13 diff
(93.9 %id)
BF354832 head_neck .e 836 to 1122 12 to 299   tiling clone,   288/300
(96 %)
11 diff
(96.4 %id)
BE830469 lung_tumor .e 838 to 1122 23 to 307       285/321
(88 %)
9 diff
(97.2 %id)
BF354841 head_neck .e 838 to 1110 275 to 4       272/284
(95 %)
0 diff
(100 %id)
BF370825 prostate_normal .e 838 to 1110 283 to 12       272/294
(92 %)
0 diff
(100 %id)
BX330418 Placenta Cot 25-normalized .e 927 to 1827 902 to 5   tiling clone,   898/903
(99 %)
14 diff
(98.5 %id)
BU733552 eye, optic nerve .e 1212 to 1830 636 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 618/618
(100 %)
2 diff
(99.7 %id)
BG291377 bladder, transitional cell papilloma, cell line .f 1 to 715 1 to 722       722/877
(82 %)
12 diff
(98.7 %id)
BM763066 myeloma .f 1 to 663 1 to 663   tiling clone,   663/663
(100 %)
2 diff
(99.7 %id)
BG740644 skin .f 15 to 831 1 to 819       819/820
(99 %)
5 diff
(99.4 %id)
BG570063 lung .f 17 to 802 1 to 796       796/925
(86 %)
20 diff
(97.9 %id)
BF679288 Prostate .f 18 to 721 1 to 704       704/867
(81 %)
18 diff
(98.0 %id)
TI_57181053   .f 27 to 886 64 to 928 T175N F176L T177H V178R K179*     865/928
(93 %)
18 diff
(98.1 %id)
TI_57215834   .f 28 to 830 26 to 830       805/830
(96 %)
10 diff
(98.8 %id)
CD723601 eye, lacrimal gland .f 30 to 633 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BI755228 brain .f 32 to 830 1 to 801       801/801
(100 %)
4 diff
(99.6 %id)
BI768558 pooled lung and spleen .f 34 to 886 1 to 859 T175N F176L T177H V178R K179*     859/859
(100 %)
12 diff
(98.7 %id)
DB458406 testis .f 41 to 509 1 to 469       469/469
(100 %)
0 diff
(100 %id)
DC358691 lung .f 42 to 602 1 to 561       561/561
(100 %)
0 diff
(100 %id)
CD511727 Blood vessels - aorta, basilar and artery .f 46 to 723 1 to 683       683/745
(91 %)
15 diff
(98.0 %id)
BQ436393 embryonal carcinoma, cell line, testis .f 49 to 1059 20 to 1037 H194T I195S I196S G197A A198Q ...     1018/1099
(92 %)
35 diff
(96.9 %id)
CN262778 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 51 to 413 1 to 363       363/363
(100 %)
0 diff
(100 %id)
BG427089 Kidney .f 51 to 813 1 to 769       769/827
(92 %)
18 diff
(97.9 %id)
BM921313 pooled brain, lung, testis .f 51 to 778 9 to 740       732/1109
(66 %)
19 diff
(98.3 %id)
BP216471 corpus callosum .f 52 to 633 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC345471 tongue, tumor tissue .f 52 to 571 1 to 520       520/520
(100 %)
0 diff
(100 %id)
DB475506 hippocampus .f 52 to 513 1 to 462       462/462
(100 %)
0 diff
(100 %id)
DB479923 hippocampus .f 52 to 556 1 to 505       505/505
(100 %)
0 diff
(100 %id)
BG427287 Kidney .f 52 to 802 1 to 751       751/759
(98 %)
8 diff
(99.0 %id)
BQ883865 dorsal root ganglia .f 52 to 901 1 to 859 G210W M211H I212D F213L S214Q ...     859/860
(99 %)
11 diff
(98.8 %id)
BP279138   .f 52 to 650 1 to 599       599/599
(100 %)
0 diff
(100 %id)
CB110516 Liver .f 52 to 427 1 to 376       376/376
(100 %)
0 diff
(100 %id)
CB111749 Liver .f 52 to 537 1 to 486       486/486
(100 %)
0 diff
(100 %id)
CB129627 Liver .f 52 to 583 1 to 532       532/532
(100 %)
0 diff
(100 %id)
CB142256 Liver .f 52 to 499 1 to 448       448/448
(100 %)
0 diff
(100 %id)
BQ427988 leiomyosarcoma, uterus .f 54 to 813 1 to 764       764/884
(86 %)
16 diff
(98.2 %id)
BE783457 eye, retinoblastoma .f 55 to 811 1 to 760       760/802
(94 %)
21 diff
(97.4 %id)
CA495290   .f 55 to 936 32 to 916 V159R E160G Q161T F162V I163Y ...     885/917
(96 %)
17 diff
(98.2 %id)
DC342327 thalamus .f 58 to 605 1 to 548       548/548
(100 %)
0 diff
(100 %id)
DC370207   .f 58 to 836 1 to 778   fully sequenced,   778/778
(100 %)
9 diff
(98.9 %id)
BM762059 myeloma .f 58 to 737 1 to 680       680/680
(100 %)
1 diff
(99.9 %id)
DC320479 brain .f 59 to 615 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BP312626 mammary gland .f 59 to 642 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP313132 mammary gland .f 59 to 641 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BM762313 myeloma .f 59 to 663 1 to 605       605/605
(100 %)
0 diff
(100 %id)
DC388670 small intestine .f 59 to 628 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BP355497   .f 59 to 639 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP361931 thalamus .f 59 to 640 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP226072   .f 61 to 642 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM742152 stomach .f 61 to 666 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM783409 stomach .f 61 to 675 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BM765807 stomach .f 61 to 663 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BM771987 stomach .f 61 to 663 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BM772012 stomach .f 61 to 652 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BM772453 stomach .f 61 to 554 1 to 494       494/494
(100 %)
0 diff
(100 %id)
BM773386 stomach .f 61 to 675 1 to 615       615/615
(100 %)
0 diff
(100 %id)
CB125762 Liver .f 63 to 668 8 to 613       606/606
(100 %)
0 diff
(100 %id)
BU930694 Prostate .f 64 to 784 1 to 731       731/764
(95 %)
12 diff
(98.5 %id)
DC371014   .f 65 to 603 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BG705220 brain, hippocampus .f 66 to 840 1 to 777       777/778
(99 %)
12 diff
(98.5 %id)
BI545708 brain, hippocampus .f 66 to 804 1 to 746       746/862
(86 %)
16 diff
(98.2 %id)
BP318610 pericardium .f 67 to 647 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BU941283 mixed (pool of 40 RNAs) .f 68 to 819 1 to 750       750/849
(88 %)
21 diff
(97.6 %id)
DR422021 eye, Pterygium .f 68 to 850 1 to 783       783/783
(100 %)
3 diff
(99.7 %id)
CV575898 cornea, eye .f 68 to 653 1 to 586       586/586
(100 %)
0 diff
(100 %id)
CN262789 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 69 to 820 1 to 754       754/754
(100 %)
2 diff
(99.8 %id)
CN483853 eye .f 69 to 553 1 to 485       485/485
(100 %)
0 diff
(100 %id)
BG029936 breast, mammary adenocarcinoma, cell line .f 69 to 868 1 to 797       797/799
(99 %)
15 diff
(98.2 %id)
BG333878 melanotic melanoma, skin .f 69 to 800 1 to 736       736/850
(86 %)
12 diff
(98.6 %id)
BG741412 skin .f 69 to 773 1 to 706       706/706
(100 %)
5 diff
(99.3 %id)
DA150818 amygdala .f 71 to 626 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CN262785 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 71 to 687 1 to 617       617/617
(100 %)
0 diff
(100 %id)
BP233359 coronary artery .f 71 to 658 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BG115102 duodenal adenocarcinoma, cell line, small intestine .f 71 to 786 1 to 709       709/923
(76 %)
14 diff
(98.5 %id)
CB989949 Human Placenta, placenta .f 71 to 794 29 to 758       730/768
(95 %)
17 diff
(97.8 %id)
TI_44166168   .f 71 to 804 126 to 866       741/982
(75 %)
17 diff
(98.3 %id)
BP377630 uterus .f 71 to 636 1 to 566       566/566
(100 %)
0 diff
(100 %id)
AU105875   .f 72 to 121 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BP260950 small intestine .f 72 to 655 1 to 584       584/584
(100 %)
0 diff
(100 %id)
CX757058 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .f 72 to 865 1 to 786     Submitted on the opposite strand 786/788
(99 %)
15 diff
(98.1 %id)
CV570094 cornea, eye .f 73 to 690 1 to 618       618/618
(100 %)
0 diff
(100 %id)
DR155525 human embryonic stem cells differentiated toan early endodermal cell type .f 76 to 853 1 to 778       778/778
(100 %)
0 diff
(100 %id)
BF209874 bone marrow, from chronic myelogenous leukemia .f 77 to 769 1 to 688       688/885
(77 %)
17 diff
(98.1 %id)
BQ135232 bladder, epithelia .f 78 to 1305 26 to 1255 P2V V3K K4G G6S T7K ... AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1230/1255
(98 %)
11 diff
(99.2 %id)
BI552470 brain, hippocampus .f 78 to 805 1 to 729       729/732
(99 %)
6 diff
(99.2 %id)
BP330843 rectum .f 78 to 654 1 to 577       577/583
(98 %)
1 diff
(99.9 %id)
CN262777 embryonic stem cells, DMSO-treated H9 cellline .f 79 to 833 1 to 755       755/755
(100 %)
0 diff
(100 %id)
BF340372 brain, glioblastoma with EGFR amplification .f 79 to 770 1 to 691       691/692
(99 %)
2 diff
(99.8 %id)
BQ582109 insulinoma, Pancreas .f 79 to 497 8 to 426     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 419/426
(98 %)
6 diff
(98.6 %id)
AA307941 colon .f 80 to 610 1 to 531       531/531
(100 %)
0 diff
(100 %id)
AW630061 2 pooled high-grade transitional celltumors, genitourinary tract .f 80 to 662 1 to 583     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 583/583
(100 %)
0 diff
(100 %id)
CD241858 Blood vessels - aorta, basilar and artery .f 80 to 828 1 to 749       749/749
(100 %)
3 diff
(99.6 %id)
CN262781 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 81 to 657 1 to 577       577/577
(100 %)
0 diff
(100 %id)
DB505366 hypothalamus .f 82 to 541 1 to 460       460/460
(100 %)
0 diff
(100 %id)
BG432366 Kidney .f 82 to 818 1 to 740       740/833
(88 %)
17 diff
(98.0 %id)
BG537495 lung .f 82 to 815 1 to 736       736/787
(93 %)
15 diff
(98.1 %id)
BG548867 lung .f 82 to 800 1 to 724       724/842
(85 %)
14 diff
(98.4 %id)
BG697690 skin .f 82 to 886 1 to 807 K119N E120G V121S Q122P E123G ...     805/807
(99 %)
8 diff
(99.1 %id)
BU602324 mixed (pool of 40 RNAs) .f 82 to 805 1 to 729       729/789
(92 %)
9 diff
(98.9 %id)
CA395809 eye, RPE/choroid .f 83 to 683 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BG500681 adenocarcinoma, Prostate .f 84 to 802 1 to 724       724/782
(92 %)
13 diff
(98.4 %id)
BM818878 stomach .f 84 to 652 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BM848783 stomach .f 84 to 536 1 to 453       453/453
(100 %)
0 diff
(100 %id)
AU105879   .f 85 to 134 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BG771429 testis .f 85 to 860 6 to 786       779/950
(82 %)
19 diff
(98.0 %id)
BP294729   .f 85 to 665 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP296601   .f 85 to 667 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP296738   .f 85 to 665 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP306441   .f 85 to 652 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BP373851 umbilical cord .f 85 to 667 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA433574 tongue, tumor tissue .f 86 to 634 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA454580 tongue, tumor tissue .f 86 to 647 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA919393 small intestine .f 86 to 649 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB018115 esophageal, tumor tissue .f 86 to 657 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BG541821 lung .f 88 to 858 1 to 783       779/913
(85 %)
26 diff
(97.2 %id)
BQ227922 epithelioid carcinoma, Pancreas .f 88 to 951 1 to 870 V199M S214R R222P R223Q N224E ...     870/871
(99 %)
16 diff
(98.2 %id)
DB481384 hippocampus .f 89 to 516 1 to 428       428/428
(100 %)
0 diff
(100 %id)
BE743667 adenocarcinoma cell line, ovary .f 89 to 914 1 to 826 Y125T K126R D127T T128P Y129T ...     826/1075
(76 %)
17 diff
(98.5 %id)
BG538788 lung .f 89 to 797 1 to 699       699/872
(80 %)
13 diff
(98.6 %id)
BG673981 skin .f 92 to 926 1 to 837 G157R V159R E160G Q161T F162V ...     837/861
(97 %)
9 diff
(99.0 %id)
BP329519 rectum .f 92 to 673 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM763238 myeloma .f 94 to 785 1 to 692       692/692
(100 %)
1 diff
(99.9 %id)
CA489736   .f 95 to 946 1 to 861 I203H A204C V205R V206G M207S ...     861/862
(99 %)
11 diff
(98.8 %id)
BG698687 skin .f 96 to 925 1 to 827 F209S     827/931
(88 %)
11 diff
(98.9 %id)
BI821066 pooled brain, lung, testis .f 96 to 897 1 to 803 K119N E120G V121S Q122P E123G ...     803/803
(100 %)
1 diff
(99.9 %id)
BI763840 pooled colon, kidney, stomach .f 96 to 766 1 to 671       671/671
(100 %)
0 diff
(100 %id)
TI_57198364   .f 96 to 897 32 to 834 K119N E120G V121S Q122P E123G ...     803/834
(96 %)
7 diff
(99.2 %id)
CN262782 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 97 to 521 1 to 425       425/425
(100 %)
0 diff
(100 %id)
BG674088 skin .f 97 to 917 1 to 828 K119Q I185H K186Q E187R V188G ...     828/1161
(71 %)
18 diff
(98.5 %id)
BP197905 adrenal gland .f 101 to 682 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP299148   .f 101 to 681 1 to 581       581/581
(100 %)
0 diff
(100 %id)
AB079244   .f 120 to 1302 42 to 1221 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1180/1221
(96 %)
9 diff
(99.3 %id)
CX788892 human embryonic stem cells .f 129 to 969 1 to 841 exact     841/841
(100 %)
0 diff
(100 %id)
BC011988 Ovary, adenocarcinoma .f 134 to 1304 1 to 1171 M215T available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1171/1171
(100 %)
1 diff
(100.0 %id)
M38690 hemopoietic system .f 134 to 1302 1 to 1167 exact tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1167/1167
(100 %)
2 diff
(99.9 %id)
BG289337 bladder, transitional cell papilloma, cell line .f 144 to 926 11 to 793 S55R F56L Y57L T58H G59R ...     783/896
(87 %)
16 diff
(98.3 %id)
BG682442 skin, squamous cell carcinoma .f 153 to 923 1 to 771 E160A Q161T F162V I163Y S164L ...     771/849
(90 %)
3 diff
(99.7 %id)
AY423720   .f 168 to 872 1 to 705 exact     705/705
(100 %)
0 diff
(100 %id)
BG741471 skin .f 179 to 934 1 to 756 I195N I196H G197R A198R V199S ...     756/815
(92 %)
7 diff
(99.2 %id)
TI_1948072602   .f 184 to 870 814 to 127       688/1271
(54 %)
3 diff
(99.8 %id)
L34068   .f 185 to 871 1 to 687 exact     687/687
(100 %)
0 diff
(100 %id)
EB386859 eye, optic nerve .f 187 to 1068 7 to 888       882/888
(99 %)
6 diff
(99.4 %id)
CD519191 White Matter .f 192 to 1058 1 to 870       870/875
(99 %)
5 diff
(99.5 %id)
EB387653 eye, optic nerve .f 208 to 955 1 to 748       748/748
(100 %)
1 diff
(99.9 %id)
TI_1948072874   .f 243 to 870 754 to 128       627/1107
(56 %)
9 diff
(99.2 %id)
TI_1948073164   .f 243 to 870 754 to 126       629/1096
(57 %)
18 diff
(98.4 %id)
TI_182940332   .f 243 to 1026 860 to 79   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 782/974
(80 %)
8 diff
(99.2 %id)
BY995462   .f 250 to 899 10 to 659       650/659
(98 %)
6 diff
(99.1 %id)
BQ719271 sympathetic trunk .f 268 to 1127 1 to 866       866/979
(88 %)
26 diff
(97.4 %id)
BG035160 adenocarcinoma, cell line, Liver .f 287 to 930 1 to 643       643/918
(70 %)
4 diff
(99.6 %id)
BI197273 brain, neuroblastoma .f 289 to 1085 1 to 799       773/897
(86 %)
24 diff
(97.4 %id)
W78208 heart .f 290 to 713 1 to 428       428/428
(100 %)
4 diff
(99.1 %id)
BP217263 corpus callosum .f 298 to 878 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BG285527 bladder, transitional cell papilloma, cell line .f 309 to 919 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BI767493 pooled lung and spleen .f 309 to 1095 1 to 785       762/792
(96 %)
17 diff
(97.9 %id)
TI_57181204   .f 309 to 1095 67 to 851       762/858
(88 %)
23 diff
(97.4 %id)
BF038898 adenocarcinoma, ovary .f 312 to 924 1 to 611       611/931
(65 %)
3 diff
(99.7 %id)
TI_57147706   .f 314 to 1113 59 to 846       788/846
(93 %)
22 diff
(97.4 %id)
BI760723 pooled colon, kidney, stomach .f 316 to 1113 1 to 786       786/786
(100 %)
16 diff
(98.0 %id)
BQ631736 Pancreas, Purified pancreatic islet .f 324 to 836 1 to 513   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 513/513
(100 %)
2 diff
(99.7 %id)
BP295064   .f 331 to 885 1 to 555       555/555
(100 %)
0 diff
(100 %id)
AA173331   .f 353 to 712 1 to 362       362/362
(100 %)
3 diff
(99.2 %id)
TI_149295621   .f 523 to 1302 858 to 95   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 764/902
(84 %)
23 diff
(97.5 %id)
TI_149297517   .f 525 to 1304 836 to 58   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 779/958
(81 %)
7 diff
(99.3 %id)
TI_154060954   .f 525 to 1308 884 to 103   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 782/963
(81 %)
12 diff
(98.8 %id)
TI_154122468   .f 531 to 1302 859 to 89   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 771/1025
(75 %)
16 diff
(98.5 %id)
TI_149309542   .f 532 to 1302 866 to 96   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 771/912
(84 %)
4 diff
(99.6 %id)
BF093705 uterus .f 533 to 930 398 to 1       398/398
(100 %)
0 diff
(100 %id)
TI_149285173   .f 533 to 1302 859 to 94   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 766/1152
(66 %)
17 diff
(98.6 %id)
TI_149300661   .f 533 to 1302 841 to 73   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 769/955
(80 %)
6 diff
(99.4 %id)
TI_149303164   .f 533 to 1302 849 to 81   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 769/953
(80 %)
12 diff
(98.8 %id)
BM709849 eye, optic nerve .f 536 to 752 1 to 217   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 217/217
(100 %)
0 diff
(100 %id)
BM830832 stomach .f 539 to 1073 1 to 535       535/535
(100 %)
0 diff
(100 %id)
CN262787 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 555 to 1299 9 to 752       744/752
(98 %)
7 diff
(99.1 %id)
BP425063 small intestine .f 556 to 1083 1 to 529     Submitted on the opposite strand 529/529
(100 %)
3 diff
(99.5 %id)
TI_154050554   .f 556 to 1303 838 to 99   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 740/972
(76 %)
9 diff
(99.1 %id)
CK430524 eye, lacrimal gland .f 571 to 1165 1 to 595       595/595
(100 %)
0 diff
(100 %id)
BM799114 Ascites, stomach .f 572 to 1079 1 to 508       508/508
(100 %)
0 diff
(100 %id)
AI041822 parathyroid gland, parathyroid tumor .f 578 to 1298 737 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 721/721
(100 %)
7 diff
(99.1 %id)
CB529247 Aveolar Macrophage, lung .f 584 to 1302 736 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 718/718
(100 %)
2 diff
(99.8 %id)
CA446245 Chondrosarcoma, Left Pubic Bone .f 587 to 1304 734 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 716/716
(100 %)
3 diff
(99.6 %id)
BU687927 lung .f 593 to 1302 728 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 710/710
(100 %)
0 diff
(100 %id)
CA309828 Alveolar Macrophage, lung .f 593 to 1302 726 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 708/708
(100 %)
2 diff
(99.8 %id)
TI_154018668   .f 604 to 1302 792 to 94   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 699/699
(100 %)
2 diff
(99.8 %id)
BQ014021 Chondrosarcoma, Left Pubic Bone .f 606 to 1298 709 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 693/693
(100 %)
1 diff
(99.9 %id)
CB529989 Aveolar Macrophage, lung .f 607 to 1304 712 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 694/694
(100 %)
7 diff
(99.0 %id)
BQ009392 Chondrosarcoma, Left Pubic Bone .f 614 to 1298 701 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 685/685
(100 %)
0 diff
(100 %id)
BI044123 ovary .f 622 to 1052 430 to 1       430/430
(100 %)
3 diff
(99.4 %id)
TI_149284960   .f 622 to 1308 765 to 79   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 687/687
(100 %)
5 diff
(99.3 %id)
TI_151739745   .f 627 to 1302 789 to 111   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 679/984
(69 %)
13 diff
(98.7 %id)
TI_154124420   .f 633 to 1302 738 to 74   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 665/923
(72 %)
5 diff
(99.5 %id)
TI_149294823   .f 639 to 1302 725 to 63   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 663/951
(69 %)
7 diff
(99.3 %id)
BU683442 lung .f 639 to 1302 681 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 663/673
(98 %)
7 diff
(99.0 %id)
TI_149291054   .f 640 to 1298 750 to 101   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 650/675
(96 %)
9 diff
(98.7 %id)
BU627007 Alveolar Macrophage, lung .f 645 to 1302 675 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 657/657
(100 %)
2 diff
(99.7 %id)
BU684244 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 649 to 1304 675 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 657/657
(100 %)
1 diff
(99.9 %id)
BM976684 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 650 to 1302 671 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 653/653
(100 %)
0 diff
(100 %id)
BM982568 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 651 to 1304 672 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 654/654
(100 %)
0 diff
(100 %id)
BQ001228 lung, Metastatic Chondrosarcoma .f 652 to 1304 671 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 653/653
(100 %)
0 diff
(100 %id)
CN479864 Knee, Osteoarthritic Cartilage .f 655 to 1302 666 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 648/648
(100 %)
1 diff
(99.9 %id)
BM981221 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 658 to 1302 663 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 645/645
(100 %)
0 diff
(100 %id)
BM505534 insulinoma, Pancreas .f 680 to 1304 640 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 625/625
(100 %)
0 diff
(100 %id)
BQ581768 insulinoma, Pancreas .f 680 to 1308 644 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 629/629
(100 %)
0 diff
(100 %id)
BQ447194 Knee, Osteoarthritic Cartilage .f 681 to 1302 641 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 623/660
(94 %)
5 diff
(99.3 %id)
BM314935 Pancreas, Purified pancreatic islet .f 686 to 1301 616 to 1       616/616
(100 %)
1 diff
(99.9 %id)
BM997650 lung, Metastatic Chondrosarcoma .f 686 to 1298 629 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 613/613
(100 %)
0 diff
(100 %id)
BG997112 head_neck .f 687 to 927 446 to 206       241/247
(97 %)
0 diff
(100 %id)
BM990226 lung, Metastatic Chondrosarcoma .f 687 to 1304 636 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 618/618
(100 %)
0 diff
(100 %id)
BU689423 lung .f 687 to 1302 634 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 616/616
(100 %)
0 diff
(100 %id)
CA419083 Chondrosarcoma Grade II, Left Pelvis .f 687 to 1302 632 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 614/614
(100 %)
2 diff
(99.7 %id)
BG993671 head_neck .f 688 to 1082 1 to 395       395/395
(100 %)
3 diff
(99.3 %id)
BU734209 eye, optic nerve .f 691 to 1302 630 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 612/612
(100 %)
0 diff
(100 %id)
CA420318 Bone, Enchondroma cell line .f 692 to 1308 635 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 617/617
(100 %)
0 diff
(100 %id)
BM679821.
matches multiple genes
eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 719 to 1008 305 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base), also hits gene GFRA1 290/313
(92 %)
0 diff
(100 %id)
BP419068 small intestine .f 749 to 1243 1 to 495     Submitted on the opposite strand 495/495
(100 %)
0 diff
(100 %id)
AA302252 aorta .f 763 to 936 1 to 173       173/173
(100 %)
1 diff
(99.5 %id)
DC426338   .f 769 to 1308 542 to 1   fully sequenced,   542/542
(100 %)
6 diff
(98.9 %id)
BQ632032 Pancreas, Purified pancreatic islet .f 775 to 1302 543 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 528/528
(100 %)
1 diff
(99.9 %id)
CA414074 Chondrosarcoma Grade II, Left Pelvis .f 786 to 1303 536 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 518/518
(100 %)
0 diff
(100 %id)
AA173437   .f 933 to 1302 377 to 7       371/377
(98 %)
0 diff
(100 %id)
AW613823 2 pooled high-grade transitional celltumors, genitourinary tract .f 953 to 1308 392 to 37   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 356/356
(100 %)
0 diff
(100 %id)
W70311 heart .f 1162 to 1302 141 to 1       141/141
(100 %)
0 diff
(100 %id)
BM466151 embryonal carcinoma, cell line, testis .g 1 to 771 1 to 780 exact tiling clone,   780/998
(78 %)
11 diff
(98.9 %id)
DB476144 hippocampus .h 1 to 461 1 to 460       460/478
(96 %)
5 diff
(99.0 %id)
DB476354 hippocampus .h 1 to 487 1 to 487   tiling clone,   487/487
(100 %)
2 diff
(99.6 %id)
BG701630 brain, hippocampus .h 50 to 838 1 to 786 Y121L K122Q D123G T124H Y125L ... tiling clone,   786/792
(99 %)
11 diff
(98.7 %id)
BP303188   .i 1 to 564 1 to 561 Q125X V140* tiling clone,   561/582
(96 %)
8 diff
(98.7 %id)
AW856410 colon .j-u 1 to 472 469 to 1   tiling clone,   469/483
(97 %)
11 diff
(97.8 %id)
BE141015 head_neck .j-u 19 to 488 1 to 469       469/469
(100 %)
6 diff
(98.8 %id)
BE141548 head_neck .j-u 27 to 311 1 to 286       286/286
(100 %)
11 diff
(96.2 %id)
BE141023 head_neck .j-u 29 to 504 500 to 26     Submitted on the opposite strand 475/505
(94 %)
0 diff
(100 %id)
BE141025 head_neck .j-u 46 to 496 33 to 482   tiling clone,   450/492
(91 %)
6 diff
(98.8 %id)
CV420412 colon .j-u 80 to 480 1 to 400       400/401
(99 %)
8 diff
(98.1 %id)
CV420395 colon .j-u 81 to 323 246 to 1     Submitted on the opposite strand 246/257
(95 %)
10 diff
(96.2 %id)
CV420411 colon .j-u 81 to 356 281 to 2     Submitted on the opposite strand 280/296
(94 %)
0 diff
(100 %id)
CV405528 head_neck .j-u 262 to 435 6 to 173   tiling clone,   168/174
(96 %)
10 diff
(94.3 %id)
BF873052 lung_tumor .j-u 318 to 439 128 to 7     Submitted on the opposite strand 122/144
(84 %)
0 diff
(100 %id)
CD642725 Embryonic Stem cells .j-u 477 to 1247 11 to 777   tiling clone,   767/780
(98 %)
12 diff
(98.5 %id)
BG222134 moderate to poorly differentiated invasivecarcinoma, tongue .j-u 772 to 1039 268 to 1   tiling clone,   268/268
(100 %)
5 diff
(98.2 %id)
AK025016 colon .j-u 1167 to 2967 1 to 1800 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1800/1800
(100 %)
2 diff
(99.9 %id)
BF883443 lung_tumor .j-u 1385 to 1815 437 to 8   tiling clone, Submitted on the opposite strand 430/437
(98 %)
0 diff
(100 %id)
BF770241 epid_tumor .j-u 2301 to 2596 533 to 237     Submitted on the opposite strand 297/533
(55 %)
0 diff
(100 %id)
BF770206 epid_tumor .j-u 2338 to 2596 516 to 258     Submitted on the opposite strand 259/516
(50 %)
0 diff
(100 %id)
AA653003   .j-u 2533 to 2936 1 to 404       404/404
(100 %)
6 diff
(98.6 %id)
AW974659   .j-u 2540 to 2967 110 to 537 exact AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 428/537
(79 %)
6 diff
(98.9 %id)
AA657926   .j-u 2540 to 2961 8 to 429       422/429
(98 %)
6 diff
(98.7 %id)
DB442287 testis .k 1 to 441 1 to 445 A4C R5A A6R P7H Q8P ... tiling clone,   445/446
(99 %)
13 diff
(97.1 %id)
CB129105 Liver .l 1 to 642 1 to 642 exact tiling clone,   642/642
(100 %)
0 diff
(100 %id)
AW377515 colon .m-u 1 to 395 17 to 416   tiling clone,   400/427
(93 %)
16 diff
(96.3 %id)
DB132020 thymus .m-u 38 to 606 2 to 570 T67K tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
AK296894 tongue, tumor tissue .n 1 to 1071 2 to 1072 A97V tiling clone,   1072/1072
(100 %)
2 diff
(99.9 %id)
DA452725 tongue, tumor tissue .n 1 to 572 2 to 573 A97V capped   572/572
(100 %)
2 diff
(99.7 %id)
DB228118 trachea .n 1 to 599 2 to 600 exact tiling clone, capped   599/599
(100 %)
0 diff
(100 %id)
AK311020 uterus .o 1 to 968 2 to 969 exact tiling clone,   969/969
(100 %)
0 diff
(100 %id)
DB267805 uterus .o 1 to 564 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB217677 trachea .o 325 to 828 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
AW799705 uterus .p 1 to 266 283 to 21 G15R tiling clone,   263/283
(92 %)
3 diff
(99.0 %id)
BE747145 adenocarcinoma cell line, ovary Gene CD9, variant not shown         Suspected internal deletion, this clone was ignored    
406 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m-u, .n, .o, .p Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI